Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ammar Alqaid"'
Publikováno v:
Southwest Respiratory and Critical Care Chronicles, Vol 3, Iss 11, Pp 35-39 (2015)
Emergence of multi-drug resistant microorganisms such as pan-resistant Pseudomonas aeruginosa has recently created a therapeutic challenge in ICU patients worldwide. New antipseudomonal antibiotics, like ceftolozane/tazobactam have been developed to
Externí odkaz:
https://doaj.org/article/d045abcf83a14495b83b169569b2e582
Autor:
Santanu Dasgupta, Julie V. Philley, Varsha Taskar, David E. Griffith, James G. Fox, Megan S. Devine, Foram Thakkar, Anbarasu Kannan, Hernaina Bains, Jeana L. Benwill, Richard J. Wallace, Barbara A. Brown-Elliott, Ammar Alqaid, Sudeep Gupta
Publikováno v:
Oncotarget
// Julie V. Philley 1 , Anbarasu Kannan 2 , David E. Griffith 1 , Megan S. Devine 1 , Jeana L. Benwill 1 , Richard J. Wallace, Jr. 1, 3 , Barbara A. Brown-Elliott 3 , Foram Thakkar 1 , Varsha Taskar 1 , James G. Fox 1 , Ammar Alqaid 1 , Hernaina Bain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98128631b0d0db2f1ba73761b5f5e3e4
https://doi.org/10.18632/oncotarget.14964
https://doi.org/10.18632/oncotarget.14964
Publikováno v:
Chest. 158:A1403-A1404
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04d98b7b6eb5c7884569965536837c5c
https://doi.org/10.1016/j.chest.2020.08.1270
https://doi.org/10.1016/j.chest.2020.08.1270
Autor:
Rishi Arora, Uzair Ghori, Aditya Sithamraju, Robert Holladay, Allen Elster, Ammar Alqaid, Paul B. Fisher, David Chambers
Publikováno v:
Chest. 158:A2658
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59bcc3e7cdcd1b296032633357b7ad01
https://doi.org/10.1016/j.chest.2020.09.273
https://doi.org/10.1016/j.chest.2020.09.273
Autor:
Paul B. Fisher, Allen Elster, Aditya Sithamraju, Robert Holladay, Ammar Alqaid, Rishi Arora, David Chambers
Publikováno v:
Chest. 158:A2656
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61792390c1b34282a03c2d1940864ece
https://doi.org/10.1016/j.chest.2020.09.271
https://doi.org/10.1016/j.chest.2020.09.271
Publikováno v:
American journal of therapeutics. 26(3)
BACKGROUND Neurocardiogenic syncope (NCS) is a common form of syncope. Although selective serotonin reuptake inhibitors and other medications have been used to treat NCS with variable success, there is no consensus regarding a first-line therapy. STU
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df7eb78431b2cdfc4b4734d82cc4a921
https://pubmed.ncbi.nlm.nih.gov/28816725
https://pubmed.ncbi.nlm.nih.gov/28816725
Publikováno v:
American journal of therapeutics. 23(4)
Amiodarone is a widely used antiarrhythmic that is used in the management of a variety of atrial and ventricular arrhythmias. Amiodarone-induced lung injury is an adverse effect in 5% of patients taking amiodarone, usually within 12 months of commenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::795a03e4f13f46070cd4916f72508464
https://pubmed.ncbi.nlm.nih.gov/25882273
https://pubmed.ncbi.nlm.nih.gov/25882273
Autor:
Ammar Alqaid, Bosko Margeta, Rizcallah Dick, Maria Octavia Rangel, Rami Doukky, Marwan Wassouf
Publikováno v:
The international journal of cardiovascular imaging. 29(5)
A subgroup analysis of the ASSUAGE trial suggested that the standardized intravenous aminophylline administration following regadenoson-stress leads to substantial attenuation of regadenoson adverse-effects in patients with severe chronic kidney dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5eceb742190978a67b9141d2c88fc83
https://pubmed.ncbi.nlm.nih.gov/23224354
https://pubmed.ncbi.nlm.nih.gov/23224354
Autor:
Ammar Alqaid, Marwan Wassouf, Rizcallah Dick, Maria Octavia Rangel, Rami Doukky, Raysa Morales Demori
Publikováno v:
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. 20(2)
There has not been any prospective evaluation of the safety and tolerability of regadenoson (REG)-stress in patients with end-stage renal disease (ESRD).From the pooled database of two identically designed randomized, double-blinded, placebo-controll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::292475fa54ab362a966c79e8f0d9e54b
https://pubmed.ncbi.nlm.nih.gov/23225540
https://pubmed.ncbi.nlm.nih.gov/23225540